drugset / Trial / NCT00008255

INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer

NCT00008255 ↗

Diagnostic

Summary

RATIONALE: Doctors can diagnose lung cancer by collecting mucus coughed up from the lungs and examining it under a microscope to look for cancer cells. Breathing in INS316 may make it easier for patients to cough up mucus. PURPOSE: Randomized phase II trial to study the effectiveness of INS316 in helping to diagnose lung cancer.

Timeline

Start
2000-08
Primary completion
—
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject INS316 Diagnostic / imaging agent — Inhaled

Indications